SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures by developing the first 3D visualization platform using real-time holography of the patient’s anatomy and catheter location, “floating” over the patients, with a goal to provide the clinician and patient a faster, safer delivery of care. Founded by Dr. Jennifer Silva, MD, Jim Howard, Jonathan Silva, and PhD in 2017, SentiAR is backed by investors that include National Institutes of Health, BioGenerator, Cultivation Capital, Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship, and Neue Fund and is headquartered in St Louis.